Cargando…
Genetically Engineered In Vitro Erythropoiesis
BACKGROUND: Engineered blood has the greatest potential to combat a predicted future shortfall in the US blood supply for transfusion treatments. Engineered blood produced from hematopoietic stem cell (HSC) derived red blood cells in a laboratory is possible, but critical barriers exist to the produ...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Stem Cell Research
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961104/ https://www.ncbi.nlm.nih.gov/pubmed/27426086 http://dx.doi.org/10.15283/ijsc.2016.9.1.53 |